Advisory
PACE has assembled advisory committees to provide strategic guidance to the programme and expertise to help select and support projects awarded funding.

Strategic Advisory Committee (SAC)
The SAC provides input and advocacy for the programme. Members are cross-sector experts in AMR. The committee provides advice and guidance to the JSB and JPMB on the strategic direction of the programme. Our SAC are not involved in the peer-review of applications for funding and do not provide recommendations on which research projects we should fund.


Professor Till Bachmann
Deputy Head of Infection Medicine & Personal Chair of Molecular Diagnostics and Infection, University of Edinburgh


Dr Ken Bradley
Global Head, Infectious Diseases Discovery Immunology, Roche Pharma Research and Early Development


Sue Charles
Independent Consultant, Charles Consultants; Member of the WHO Task Force of AMR Survivors


Nick Crabb
CSO for Science, Evidence and Analytics, AMR Lead, NICE


Helen Dent
CEO, BIVDA


Dr Erin Duffy
Chief of Research & Development, CARB-X


Professor Sir Michael Ferguson
Regius Professor of Life Sciences, University of Dundee


Professor William Hope
Dame Sally Davies Chair of AMR Research, University of Liverpool


Dr Seamus O'Brien
R&D Director, GARDP


Dr Lesley Ogilvie
Secretariat Director, Global AMR R&D Hub


Dr Deborah O’Neill
CEO, Novabiotics


Dr Maneesh Paul
CEO, Microvioma


Dr Alexander Pym
Director of Infectious Disease, Wellcome


Florence Sejourne
CEO, Aurobac


Professor Mary de Silva
Deputy Chief Scientific Advisor, DHSC


Kirsteen Wills
CEO, AMR Action UK
Scientific Projects Advisory Groups (SPAG)
SPAG members are experts in AMR research and development. They provide scientific review and assessment of research proposals as part of our funding call process and ongoing portfolio monitoring. They provide recommendations and advice to the JPMB. If necessary, more than one SPAG will be convened during the programme to complement the funding round at the time (e.g. therapeutics and diagnostics).
Antibacterial Therapeutics SPAG


Dr Lloyd Czaplewski (Chair)
Independent Consultant, Chemical Biology Ventures Ltd; CSO, Persica


Dr Nel Moore (Deputy Chair)
Independent Consultant, FW East Consulting


Professor Stephen Baker
Professor and Director of Research Global Health, University of Cambridge


Dr Benjamin Blasco
Senior Discovery Manager, GARDP


Dr Patricia Bradford
Independent Consultant, Antimicrobial Development Specialists


Professor Karen Bush
Professor of Practice Emerita, Indiana University Bloomington


Dr Jason Clark
CSO, NexaBiome


Professor Martha Clokie
Professor of Microbiology, University of Leicester


Dr Aleksandar Danilovski
Independent Consultant; DALISCO d.o.o.


Dr Alice Erwin
Independent Consultant, Erwin Consulting LLC


Professor Ian Gilbert
Professor of Drug Discovery, Drug Discovery Unit, University of Dundee


Dr Hideki Maki
Principal Investigator, Shionogi


Dr Ralph Minter
Senior VP of Research, Alchemab Therapeutics Ltd


Dr Claire Sadler
Independent Consultant, Sadler Scientific; Senior Toxicologist, Apconix


Dr Bala Subramanian
CSO, Bugworks


Dr Peter Warn
Independent Consultant, Magic Bullet Consulting
Antibacterial Diagnostics SPAG


Philip Jordan (Chair)
Principal - Licensing and Ventures Manager, Oxford University Innovation Limited, UK


Sabine Dittrich (Deputy)
Professor for Global Public Health, Deggendorf Institute of Technology, Germany


Joy Allen
Head of Market Access and Public Affairs, Roche Diagnostics UK and Ireland


Akhil Bansal
Policy Fellow, Centre for Global Development, UK; Medical Doctor, Royal Free London NHS Foundation Trust, UK


Jane Cunningham
Consultant in Infectious Diseases and Microbiology, University Hospitals Dorset NHS Foundation Trust, UK


Jayne Ellis
Associate Professor in Clinical Microbiology, University of Leeds, UK; Clinical Scientist, Leeds Teaching Hospitals NHS Trust, UK


Nina Garrett
Chief Technical Officer, Abingdon Health, UK


Namita Jaggi
Chairperson, Labs and Infection Control, Artemis Hospitals, India; Medical Doctor, India


Karen Jordan-Coffey
Clinical Marketing Director, bioMérieux UK Ltd, UK


Gorm Lisby
Chief Consultant, Hvidovre Hospital, Copenhagen, Denmark


Colleen Loynachan
Senior Technical Advisor, International Pandemic Preparedness Secretariat, UK


Jonathan Perkins
Independent Consultant and Scientific Advisor, UK


Giles Sanders
Head of Diagnostics, The Technology Partnership (TTP), UK


John Tyson
Head of North-East Innovation Lab, Newcastle Hospitals, UK


Betsy Wonderly-Trainor
Alliance Director, CARB-X, US
Extended Advisory Network
Together with SPAG members, these scientific advisors are part of PACE’s broader expert network. They support our portfolio projects in a range of ways, including participation in scientific advisory boards and the provision of specialist input to help advance projects.


Professor Jo Fothergill
Professor in Medical Microbiology, University of Liverpool


Professor Colin Hill
Professor of Microbiology, University College Cork


Dr Zoltán Magyarics
Vice-President, Research and Development, AOP Health


Dr Margarida Saraiva
Group leader at i3S-Porto, Portugal
AMR Community Representatives Committee (ACRC)
The voices of people with lived experience of AMR are integral to PACE. The ACRC reviews proposals from a patient and public perspective, providing insight, input and feedback to applications submitted as part of our funding calls and as part of ongoing portfolio delivery. In this way we are promoting a more person-centred approach to PACE funded research, resulting in better outcomes for all.
We partnered with Vocal, a non-profit patient and public involvement and engagement organisation that specialises in connecting people to health research, to assemble the ACRC. Vocal hosts a network of people affected by AMR, as either patients or carers, and to date 13 members of this AMR community are involved in the ACRC. Learn more about Vocal and the AMR network.


Apply to join one of the PACE advisory committees
Apply Here
